CheckPoint Software Case Studies Enhancing Security in Biotechnology: Gnosis SpA's Journey with Check Point Security Solutions

Edit This Case Study Record

	Enhancing Security in Biotechnology: Gnosis SpA's Journey with Check Point Security Solutions CheckPoint Software

Enhancing Security in Biotechnology: Gnosis SpA's Journey with Check Point Security Solutions

CheckPoint Software

Technology Category	Analytics & Modeling - Machine Learning Sensors - Level Sensors
Applicable Industries	Mining National Security & Defense
Applicable Functions	Facility Management
Use Cases	Cybersecurity Tamper Detection
Challenge	Gnosis SpA, an Italian biotechnology company, was facing a growing security challenge due to its rapid expansion. The company's increased attack surface was becoming more susceptible to zero-day and other advanced threats. As a pharmaceutical company, Gnosis had to comply with strict government security regulations, which were increasingly focusing on system security in facilities such as laboratories and manufacturing facilities. However, Gnosis' legacy systems were not equipped to prevent advanced threats from gaining access. The company needed a more efficient, consolidated security solution that could protect its network, data, and communications between its headquarters and other sites. It was looking for a next-generation solution to protect against advanced threats targeting employees, visitors, suppliers, websites, and outgoing communications like email. Read More
About Customer	Gnosis SpA is a leading biotechnology company with over 20 years of experience in microbial fermentation for oral- and injectable-grade, microbial-derived biopharmaceuticals. The company specializes in the fermentation, purification, and chemical synthesis of raw materials and natural finished products used in the pharmaceutical, nutraceutical, cosmetic, veterinary, and agricultural industries. With locations in Italy, Switzerland, the U.S., and China, Gnosis has grown rapidly, expanding its operations and increasing its attack surface. Read More
Solution	After evaluating several cybersecurity providers listed in the Gartner Magic Quadrant, Gnosis chose Check Point SandBlast ZeroDay Protection to secure its networks and data against zero-day threats. It also deployed Check Point Next Generation Threat Prevention (NGTP) with multi-layered protection from known, signature-based threats. Gnosis utilized Check Point's firewall services, app control, intrusion prevention, perimeter antivirus, antibot, antispam, and URL filtering capabilities. It also adopted Threat Emulation and Threat Extraction technologies, which include evasion-resistant CPU-level exploit detection, machine learning, and Push-Forward Adobe Flash emulation. In addition to the NGTP capabilities that protect against all known threats, Gnosis chose SandBlast Zero-Day Protection, which protects SMTP, HTTP, and HTTPS traffic from all unknown threats—zero-day, cryptolocker, Advanced Persistent Threats (APT), and others. CPU Level Protection blocks malwares intended to bypass sandbox technologies protection. Read More Log in to view content
Contents

Technology Category

Analytics & Modeling - Machine Learning

Sensors - Level Sensors

Applicable Industries

Mining

National Security & Defense

Applicable Functions

Facility Management

Use Cases

Cybersecurity

Tamper Detection

Challenge

Gnosis SpA, an Italian biotechnology company, was facing a growing security challenge due to its rapid expansion. The company's increased attack surface was becoming more susceptible to zero-day and other advanced threats. As a pharmaceutical company, Gnosis had to comply with strict government security regulations, which were increasingly focusing on system security in facilities such as laboratories and manufacturing facilities. However, Gnosis' legacy systems were not equipped to prevent advanced threats from gaining access. The company needed a more efficient, consolidated security solution that could protect its network, data, and communications between its headquarters and other sites. It was looking for a next-generation solution to protect against advanced threats targeting employees, visitors, suppliers, websites, and outgoing communications like email.

About Customer

Gnosis SpA is a leading biotechnology company with over 20 years of experience in microbial fermentation for oral- and injectable-grade, microbial-derived biopharmaceuticals. The company specializes in the fermentation, purification, and chemical synthesis of raw materials and natural finished products used in the pharmaceutical, nutraceutical, cosmetic, veterinary, and agricultural industries. With locations in Italy, Switzerland, the U.S., and China, Gnosis has grown rapidly, expanding its operations and increasing its attack surface.

Solution

After evaluating several cybersecurity providers listed in the Gartner Magic Quadrant, Gnosis chose Check Point SandBlast ZeroDay Protection to secure its networks and data against zero-day threats. It also deployed Check Point Next Generation Threat Prevention (NGTP) with multi-layered protection from known, signature-based threats. Gnosis utilized Check Point's firewall services, app control, intrusion prevention, perimeter antivirus, antibot, antispam, and URL filtering capabilities. It also adopted Threat Emulation and Threat Extraction technologies, which include evasion-resistant CPU-level exploit detection, machine learning, and Push-Forward Adobe Flash emulation. In addition to the NGTP capabilities that protect against all known threats, Gnosis chose SandBlast Zero-Day Protection, which protects SMTP, HTTP, and HTTPS traffic from all unknown threats—zero-day, cryptolocker, Advanced Persistent Threats (APT), and others. CPU Level Protection blocks malwares intended to bypass sandbox technologies protection.

Impact #1	The implementation of Check Point's security solutions has significantly improved Gnosis' security posture. The company now has advanced protection against zero-day threats and has reduced operational overhead with simplified management. The solution has enabled Gnosis to protect not only its headquarters but also its labs and other facilities. The company can now control everything from a single dashboard at headquarters, greatly simplifying management while improving protection. The investment in Check Point's solutions is seen as an investment in reliability and security, ensuring business continuity in a secured environment and maintaining Gnosis’ high level of customer experience.

Impact #1

The implementation of Check Point's security solutions has significantly improved Gnosis' security posture. The company now has advanced protection against zero-day threats and has reduced operational overhead with simplified management. The solution has enabled Gnosis to protect not only its headquarters but also its labs and other facilities. The company can now control everything from a single dashboard at headquarters, greatly simplifying management while improving protection. The investment in Check Point's solutions is seen as an investment in reliability and security, ensuring business continuity in a secured environment and maintaining Gnosis’ high level of customer experience.

Benefit #1	Gnosis was able to implement specific Internet browsing policies by department
Benefit #2	The company ensured security for VPN traffic between its locations
Benefit #3	URL and web filtering were implemented to prevent junkware and threats from accessing the company’s network

Benefit #1

Gnosis was able to implement specific Internet browsing policies by department

Benefit #2

The company ensured security for VPN traffic between its locations

Benefit #3

URL and web filtering were implemented to prevent junkware and threats from accessing the company’s network

Download PDF Version

Overview

Enhancing Security in Biotechnology: Gnosis SpA's Journey with Check Point Security Solutions

Operational Impact

Quantitative Benefit